Clinical trial
In Vitro Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
NCT06842316 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In Vitro Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Lead sponsor
- Centre Hospitalier Régional d'Orléans
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 10, 2025
- Completion date
- April 9, 2027
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthritis, psoriatic, arthritis, rheumatoid, inflammatory bowel diseases, inflammatory disorder of immune system, lupus erythematosus, systemic, sjogren's syndrome, spondylitis, ankylosing